Literature DB >> 30291853

A Mesenchymal stem cell line (B10) increases angiogenesis in a rat MCAO model.

Abdullah Md Sheikh1, Shozo Yano1, Shingo Mitaki2, Md Ahsanul Haque2, Shuhei Yamaguchi2, Atsushi Nagai3.   

Abstract

A human mesenchymal stem cell line (B10) transplantation has been shown to improve ischemia-induced neurological deficits in animal stroke models. To understand the underlying mechanism, we have investigated the effects of B10 transplantation on cerebral angiogenesis in a rat middle cerebral artery occlusion (MCAO) model. B10 cells were transplanted intravenously 24 h after MCAO. Immunofluorescence staining results showed that compared to PBS-groups, vWF positive vessel and endoglin positive new vessels were increased in B10-transplanted MCAO groups in the lesion areas. The mRNA of angiogenesis factors including placental growth factor and hypoxia inducible factor (HIF)-1α were increased 3 days after MCAO in the core and IBZ areas of B10-transplanted group. Angiopoetin1 mRNA was increased only in the IBZ. Western blotting results showed that HIF-1α and vascular endothelial growth factor (VEGF) proteins were increased in B10-transplanted group. Both HIF-1α and VEGF were expressed in macrophage/microglia in the core area. In the IBZ, however, HIF-1α was expressed both in astrocytes and macrophage/microglia, while VEGF was expressed only in macrophage/microglia. Moreover, TGFβ protein levels were found to be increased in B10-transplanted group in the core and IBZ regions. Cell culture experiments using a human microglia cell line (HMO6) and B10 showed that IL-1β induced VEGF mRNA expression in both cell types. IL-1β was found to be highly expressed in B10 cells, and its co-culture with HMO6 further increased that in B10. Co-culture increased VEGF mRNA in both B10 and HMO6. In the rat brains, IL-1β was expressed in macrophage/microglia and transplanted-B10 cells in the core. IL-1β positive cell number was increased slightly, but significantly in B10-transplanted rats. To explore further, IL-1β expression was silenced in B10 cells by transfecting mRNA specific siRNA, and then transplanted in MCAO rats. Immunostaining result showed that endoglin positive area was decreased in IL-1β-silenced B10 transplanted groups compared to nonsilenced-B10 transplanted groups. Interestingly, vessel-like structure appeared as early as 3 days after MCAO in IL-1β-silenced B10-transplanted group. Thus our results demonstrated that B10 cells increased angiogenesis in MCAO rat model, through the regulation of HIF-1α and VEGF expression, where IL-1β might play a role.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; HIF-1α; IL-1β; MCAO; Mesenchymal stem cell line (B10); Transplantation; VEGF

Mesh:

Year:  2018        PMID: 30291853     DOI: 10.1016/j.expneurol.2018.10.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

Review 1.  Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.

Authors:  Ania Dabrowski; Thomas J Robinson; Ryan J Felling
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-02       Impact factor: 5.081

Review 2.  Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges.

Authors:  Afsaneh Asgari Taei; Pariya Khodabakhsh; Sanaz Nasoohi; Maryam Farahmandfar; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2022-08-03       Impact factor: 5.682

Review 3.  Extracellular Vesicle Application as a Novel Therapeutic Strategy for Ischemic Stroke.

Authors:  Yiyang Li; Bowen Liu; Ying Chen; Xingping Quan; Yan Han; Ying Zheng; Yonghua Zhao
Journal:  Transl Stroke Res       Date:  2021-05-13       Impact factor: 6.829

4.  [Research progress of different types of stem cells in treatment of ischemic stroke].

Authors:  Qiuzhu Chen; Ling Li; Huiqi Xie
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

Review 5.  MicroRNA-126: A new and promising player in lung cancer.

Authors:  Qijun Chen; Shuanghua Chen; Juanjuan Zhao; Ya Zhou; Lin Xu
Journal:  Oncol Lett       Date:  2020-11-12       Impact factor: 2.967

Review 6.  Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies.

Authors:  Guoyang Zhou; Yongjie Wang; Shiqi Gao; Xiongjie Fu; Yang Cao; Yucong Peng; Jianfeng Zhuang; Junwen Hu; Anwen Shao; Lin Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 7.  Mesenchymal Stem Cells for Neurological Disorders.

Authors:  Anna Andrzejewska; Sylwia Dabrowska; Barbara Lukomska; Miroslaw Janowski
Journal:  Adv Sci (Weinh)       Date:  2021-02-24       Impact factor: 16.806

8.  Transforming growth factor‑β1 functions as a competitive endogenous RNA that ameliorates intracranial hemorrhage injury by sponging microRNA‑93‑5p.

Authors:  Han Wang; Xianming Cao; Xiaoqing Wen; Dongling Li; Yetong Ouyang; Bing Bao; Yuqin Zhong; Zhengfang Qin; Min Yin; Zhiying Chen; Xiaoping Yin
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

Review 9.  Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke.

Authors:  Yinghan Guo; Yucong Peng; Hanhai Zeng; Gao Chen
Journal:  Stem Cells Int       Date:  2021-06-15       Impact factor: 5.443

Review 10.  Microglia and Macrophages in Neuroprotection, Neurogenesis, and Emerging Therapies for Stroke.

Authors:  Susanna R Var; Anala V Shetty; Andrew W Grande; Walter C Low; Maxim C Cheeran
Journal:  Cells       Date:  2021-12-16       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.